Maternal cardiovascular risk after hypertensive disorder of pregnancy
- PMID: 32404402
- DOI: 10.1136/heartjnl-2020-316541
Maternal cardiovascular risk after hypertensive disorder of pregnancy
Abstract
Background and objective: Hypertensive disorders of pregnancy (HDPs) affect 5%-10% of pregnancies and have been associated with excess maternal cardiovascular disease (CVD) risk. The primary aim of this study was to reliably estimate absolute and relative risks of CVD after HDP.
Methods: A retrospective cohort of women who had singleton pregnancies in New South Wales, Australia, between 2002 and 2016 and identified using linked population health administrative databases. The primary exposure was new-onset HDP (pre-eclampsia/eclampsia and gestational hypertension), and the endpoint was hospitalisation or death due to ischaemic or hypertensive heart disease, or stroke. Kaplan-Meier analysis estimated risks among mothers following their first birth, and multivariable time-dependent Cox regression estimated the association between HDP and CVD.
Results: Among 528 106 women, 10.3% experienced HDP in their first pregnancy. The 10-year estimated risk of CVD was 2.1 per 1000 if no HDP and 5.5 per 1000 following HDP. Adjusting for demographics, gestational diabetes, small for gestational age and preterm birth, we found that there was an interaction between smoking and HDP, and a larger effect of early-onset (<34 weeks) HDP, compared with late-onset HDP. The HR for women with early-onset HDP who did not smoke was 4.90 (95% CI 3.00 to 7.80) and the HR for those who did smoke was 23.5 (95% CI 13.5 to 40.5), each compared with women without HDP who did not smoke.
Conclusion: In this nationally representative Australian cohort, HDP, especially early onset, conferred a clear increase in the risk of CVD, with amplification by smoking. Targeted preventive health, during and after pregnancy, could prevent a substantial burden of CVD among childbearing women.
Keywords: diabetes; hypertension; pregnancy; smoking cessation.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: MW has received consulting fees from Amgen, Inc, and Kyowa Kirin Co, Ltd.
Similar articles
-
Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study.PLoS Med. 2021 Sep 28;18(9):e1003805. doi: 10.1371/journal.pmed.1003805. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34582464 Free PMC article.
-
Maternal hypertensive disorders during pregnancy and the risk of offspring diabetes mellitus in childhood, adolescence, and early adulthood: a nationwide population-based cohort study.BMC Med. 2023 Feb 16;21(1):59. doi: 10.1186/s12916-023-02762-5. BMC Med. 2023. PMID: 36797785 Free PMC article.
-
Heterogeneity in the risk of cardiovascular disease mortality after the hypertensive disorders of pregnancy across mothers' lifetime reproductive history.Paediatr Perinat Epidemiol. 2024 Mar;38(3):230-237. doi: 10.1111/ppe.13059. Epub 2024 Feb 21. Paediatr Perinat Epidemiol. 2024. PMID: 38380741
-
Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre-eclampsia: a systematic review and meta-analysis.BJOG. 2021 Feb;128(3):495-503. doi: 10.1111/1471-0528.16545. Epub 2020 Oct 21. BJOG. 2021. PMID: 32981216
-
Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy.Heart. 2019 Aug;105(16):1273-1278. doi: 10.1136/heartjnl-2018-313453. Epub 2019 Jun 7. Heart. 2019. PMID: 31175138 Free PMC article. Review.
Cited by
-
Prevalence of pre-eclampsia and adverse pregnancy outcomes in women with pre-existing cardiomyopathy: a multi-centre retrospective cohort study.Sci Rep. 2023 Jan 4;13(1):153. doi: 10.1038/s41598-022-26606-z. Sci Rep. 2023. PMID: 36599871 Free PMC article.
-
Postnatal Enalapril to Improve Cardiovascular Function Following Preterm Preeclampsia (PICk-UP):: A Randomized Double-Blind Placebo-Controlled Feasibility Trial.Hypertension. 2020 Dec;76(6):1828-1837. doi: 10.1161/HYPERTENSIONAHA.120.15875. Epub 2020 Oct 5. Hypertension. 2020. PMID: 33012200 Free PMC article. Clinical Trial.
-
Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.CJC Open. 2021 Aug 20;3(12 Suppl):S102-S117. doi: 10.1016/j.cjco.2021.08.002. eCollection 2021 Dec. CJC Open. 2021. PMID: 34993440 Free PMC article. Review.
-
A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum.Ther Adv Reprod Health. 2021 Feb 4;15:2633494120986544. doi: 10.1177/2633494120986544. eCollection 2021 Jan-Dec. Ther Adv Reprod Health. 2021. PMID: 33615227 Free PMC article. Review.
-
Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.Inflammation. 2021 Oct;44(5):1663-1682. doi: 10.1007/s10753-021-01455-6. Epub 2021 Apr 5. Inflammation. 2021. PMID: 33821395 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical